Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period

NCT01082328 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria

Interventions

DRUG: Kuvan®

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]
[object Object]